Venus Remedies gets approval to market cancer drugs in Serbia

Venus Remedies, a pharmaceutical company, received marketing approval from Serbia for its cancer-treatment medications.

"The company has secured marketing authorisation from Serbia for gemcitabine and docetaxel, widely used chemotherapy drugs beneficial in the treatment of various types of cancer. With this, Venus Remedies has now secured a total of 511 marketing approvals for its oncology products across 66 countries," the company said in a regulatory filing with the exchanges.

"We have more than 40 marketing authorisations in South Eastern Europe and Balkan region, including nine for oncology drugs. The marketing authorisation from Serbia is a significant milestone that will help improve access to affordable cancer drugs in the region," said Aditi Chaudhary, president of international business at Venus Remedies.

Venus Remedies is a pharmaceutical manufacturing company. The company specializes in producing various formulations in the therapeutic segment such as antibiotics, oncology drugs, and critical care medicines.